TREATMENT FOR ADVANCED PANCREATIC CANCER

Clinical trials for TREATMENT FOR ADVANCED PANCREATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new TREATMENT FOR ADVANCED PANCREATIC CANCER trials appear

Sign up with your email to follow new studies for TREATMENT FOR ADVANCED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug duo targets Tough-to-Treat stomach and pancreatic cancers

Disease control Not yet recruiting

This study is testing whether combining two drugs, tunlametinib and an anti-EGFR antibody, can help control advanced colorectal or pancreatic cancer in patients whose cancer has a specific genetic change called a RAS mutation. It will involve about 90 adults whose cancer has wors…

Matched conditions: TREATMENT FOR ADVANCED PANCREATIC CANCER

Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

TREATMENT FOR ADVANCED PANCREATIC CANCER

Get alerted when new TREATMENT FOR ADVANCED PANCREATIC CANCER trials appear

New drug duo targets Tough-to-Treat stomach and pancreatic cancers